Reaction
Perioral Dermatitis reporting signals
As of the last recalculation, Perioral Dermatitis appears in 604 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 24.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 11 | 24.6 | 24.6 |
| Dupilumab | 194 | 20.0 | 20.0 |
| Crisaborole | 4 | 14.5 | 14.5 |
| Glycerin, Lidocaine | 3 | 7.4 | 7.4 |
| Docosanol | 3 | 7.1 | 7.1 |
| Adapalene | 33 | 6.5 | 6.5 |
| Salicylic Acid | 5 | 3.3 | 3.3 |